medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2010, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2010; 55 (1)

Oncofertility

Steta MJR, Gallo SP, Almanza R, Álvarez-Valero R

Language: Spanish
References: 17
Page: 33-37
PDF size: 113.09 Kb.


ABSTRACT

The reproductive future of patients with cancer becomes threatened when therapies available exert a high impact upon germinal cells. This has generated an emergent medical discipline named oncofertility, promoted by the effectiveness of newer forms of therapy like those observed in patients with pediatric cancer which provide survival rates of 75%. Women show more limitations for fertility rescue due to the nature of their germ cells less susceptible of preservation than its male counterpart. This has led to research of promising complex techniques for follicular preservation which entails novel basis of physician-patient interaction.


REFERENCES

  1. Schover IR. Motivation for parenthood after cancer: A review. J Natl Cancer Inst Monogr 2005; 34: 2-5.

  2. Oncofertility Fertility Preservation for Cancer Survivors Series: Cancer Treatment and Research. Woodruff TK, Snyder KA (eds). New York: Springer; 2008; vol 138.

  3. Chindarkar SU. IVF-MESA (Microepididymal sperm aspiration. ezine@rticles.com (June, 2009).

  4. Magelssen H. Twenty years experience with semen cryopreservation in testicular cancer patients: Who needs it? Eur Urol 2005; 48: 779-785.

  5. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004; 10: 251-266.

  6. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: An underused procedure. Am J Obstet Gynecol 2003; 188: 367-370.

  7. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6: 209-218.

  8. Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2004; 82: 993-998.

  9. Eppig JJ, O’ Brien MJ. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 1996; 54: 197-207.

  10. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ. Intercellular communication in the mammalian ovary: Oocytes carry the conversation. Science, 2002; 296: 2178-2180.

  11. Xu M, Kreeger PK, Shea LD, Woodruff TK. Tissue-engineered follicles produce live, fertile offspring. Tissue Eng 2006; 12: 2739-2746.

  12. Xu M, West E, Shea LD, Woodruff TK. Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol Reprod 2006; 75: 916-923.

  13. Shea LD, Woodruff TK, Lowe MP. Perspectives on oncofertility. Endocrine News 2008; June: 15-19.

  14. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999; 20: 45-53.

  15. Toxicity assays: Reality Check. Nature Nanotechnology 2009; 4: 277.

  16. Donnez J, Dolmans MN, Demylle D, Oktay K, Buyuk E, Veeck L. Live birth after Orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-1410.

  17. Meirow D, Levron J, Eldar-Geva T. Pregnancy after transplantation of Cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353: 318-321.




2020     |     www.medigraphic.com